| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,121 |
15,722 |
$1.19M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,442 |
8,700 |
$1.08M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,688 |
1,318 |
$152K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,392 |
1,269 |
$152K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,406 |
1,279 |
$134K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,008 |
931 |
$101K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,718 |
3,012 |
$79K |
| 92550 |
|
9,154 |
6,023 |
$62K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,408 |
3,771 |
$56K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
4,581 |
4,056 |
$48K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,148 |
712 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,937 |
4,178 |
$30K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
455 |
229 |
$26K |
| 90461 |
|
1,189 |
1,002 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
74 |
69 |
$10K |
| 97802 |
|
1,156 |
1,094 |
$8K |
| A4927 |
Gloves, non-sterile, per 100 |
1,481 |
994 |
$7K |
| 95117 |
|
2,486 |
955 |
$7K |
| 99384 |
|
21 |
19 |
$4K |
| 69210 |
|
221 |
176 |
$4K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
584 |
516 |
$4K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
248 |
224 |
$4K |
| 99383 |
|
28 |
17 |
$4K |
| 90671 |
|
74 |
69 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,900 |
2,527 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
196 |
155 |
$3K |
| 87807 |
|
185 |
146 |
$2K |
| 96127 |
|
876 |
804 |
$870.63 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
25 |
12 |
$616.56 |
| 99460 |
|
27 |
12 |
$497.48 |
| 0001A |
|
54 |
53 |
$440.00 |
| 90697 |
|
28 |
26 |
$319.57 |
| 92567 |
|
544 |
409 |
$57.43 |
| 90734 |
|
244 |
199 |
$48.02 |
| 85018 |
|
825 |
766 |
$21.87 |
| 99051 |
|
530 |
446 |
$15.14 |
| 90670 |
|
437 |
396 |
$0.01 |
| 90648 |
|
438 |
389 |
$0.01 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
210 |
140 |
$0.00 |
| 90686 |
|
1,193 |
1,060 |
$0.00 |
| 90651 |
|
252 |
231 |
$0.00 |
| 90688 |
|
332 |
189 |
$0.00 |
| 90680 |
|
83 |
76 |
$0.00 |
| 90723 |
|
238 |
209 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
61 |
30 |
$0.00 |
| 36416 |
|
726 |
699 |
$0.00 |
| 90620 |
|
97 |
70 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
52 |
31 |
$0.00 |
| 90657 |
|
13 |
13 |
$0.00 |
| 99173 |
|
2,665 |
2,175 |
$0.00 |
| 90633 |
|
332 |
315 |
$0.00 |
| 91300 |
|
160 |
117 |
$0.00 |
| 90710 |
|
14 |
13 |
$0.00 |
| 90715 |
|
66 |
61 |
$0.00 |
| 0002A |
|
14 |
14 |
$0.00 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
26 |
26 |
$0.00 |